News Focus
News Focus
icon url

chrisand813

08/22/12 12:26 PM

#88053 RE: Seanf812 #88050

That's exactly correct that alpha trade story is total bs. Would not be surprised if we close green.
icon url

Robert C Jonson

08/22/12 12:37 PM

#88059 RE: Seanf812 #88050

I am not sure if SA lets writers delete comments, but that is certainly what it seems, because there have been no comments passed 9:30.

Yes there have......you just have to click the "Load more comments" tab.
icon url

Protector

08/12/13 10:55 AM

#136183 RE: Seanf812 #88050

Seanf812, They are in Malaysia, behind a private Hong Kong registrar registered URL and hosted by kuih.my in Malaysia.
Well that or the Canary Islands its all sunny, isn't it!

This is the full PPHM article of August 2012 during the run-up to the September 7th events.

Full 10 page PPHM PDF

They have no names, phone, or what so ever and Yang Yu cannot be traced - under that name :) The URL is NOT registered as Apsara Biotech (can not disclose as Honk Kong registrar tries to keep it private - and I don't want to shock anybody to death here :)

Of course we know now how wrong Yang Yu :) was about PPHM's NSCLC.

On Seeking Alpha, this so said professional company publishes anonymously about PPHM. How telling is that. On there own web-site they are almost invisible to themselves Apsara Biotech yet someone produced 10 pages, including graphics and a going back to the PPHM Travastin era. A document that would take me a considerable effort if I had to research and write it!

But it gets even better. For those who follow biopharm's and Eyebuystox research posts:

4 of their next 5 articles are about a company called Alnylam. Alnylam is the company that bought the RNAi patents from Satish Chandran's old company, Nucleonics.

source: sharp observation by EBS on this page.